Recombine Roundup!


Fertility Patients and Mental Health

A study of patients of five San Francisco area fertility clinics suggests that mental health issues are not adequately addressed in fertility centers. While over 75% of women undergoing fertility treatments showed symptoms of depression, only 27% of them received information on mental health services. The authors of the study list cost and tight schedule of fertility treatments as a barrier for patients seeking mental health services and propose that clinics have a mental health professional in-house.

LGBT Fertility Education 

A recent study conducted by the Boston University School of Medicine reports a lack of informational materials for the LGBT patients compared to heterosexual patients. As part of the study, investigators surveyed CDC and fertility center websites for information directed to LGBT patients. The researchers suggest there may be unequal access to care for LGBT patients and advise that creating appropriate educational materials is one way to address health care disparity in the fertility space.

A New First

The first gene therapy for children was approved in Europe to treat a type of severe combined immunodeficiency (ADA-SCID). The treatment, called Strimvelis, proved successful in repairing the faulty gene in all 18 children involved in the clinical trial. As part of the treatment, the gene responsible for ADA-SCID is repaired in the patient’s stem cells which are then reintroduced to the body.

The (un)Finished Genome

The Human Genome Project completed in 2003 is actually “99% complete”. As sequencing technology gets better, should we take a stab at the last 1% which holds about 200 genes?


Thanks for reading!


About Author

Stephany Foster

Stephany Foster is the Associate Scientific Writer at Recombine, a genetic testing company based in New York City. She writes on topics spanning fertility, reproductive medicine, and recent advances in genomics. Stephany also writes about recently published research that Recombine presents at conferences and meetings around the globe. Before joining Recombine, Stephany interned at the George Church Lab at Harvard Medical School. She graduated from Brown University with an A.B. in Biology in 2014.